Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-09-016695
Filing Date
2009-12-10
Accepted
2009-12-10 15:57:29
Documents
1
Period of Report
2009-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 3355
  Complete submission text file 0001179110-09-016695.txt   5234
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ELLIOTT AVE W STE 500 SEATTLE WA 981194114
Business Address
JACKSON MICHAEL K (Reporting) CIK: 0001287535 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-16614 | Film No.: 091233784